Accessibility Menu

Recordati Industria Chimica E Farmaceutica S.p.A.(FRA) RER1

Market Cap€10.75BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€52.40
-0.19%
-0.10Today

Recordati Industria Chimica E Farmaceutica S.p.A. Financials at a Glance

Market Cap

€10.75BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€2.71K

Net Income (TTM)

€497.18

EPS (TTM)

€2.38

P/E Ratio

21.61

Dividend

€1.34

Beta (Volatility)

0.01 (Low)

Price

€52.40

Volume

0

Open

€52.15

Previous Close

€52.40

Daily Range

€52.15 - €52.50

52-Week Range

€43.92 - €54.40

Estimated Earnings Date

N/A

RER1 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Recordati Industria Chimica E Farmaceutica S.p.A.

Recordati SpA engages in the research, development, manufacture, and marketing of pharmaceuticals. It operates through the Specialty and Primary Care, and Rare Diseases Pharmaceuticals segments. The Specialty and Primary Care segment is related to pharmaceutical chemicals business. The Rare Diseases Pharmaceuticals segment focuses on the treatments for rare diseases. The company was founded by Giovanni Recordati in 1926 and is headquartered in Milan, Italy.

Industry

Pharmaceuticals

Sector

Health Care

Employees

4,693

CEO

Robert Koremans, MD

Website

www.recordati.it

RER1 Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

24.85%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

4.63%

Dividend Yield

2.55%

Payout Ratio

N/A

Stock Overview

Market Cap

€10.75BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

204.81M

Volume

0

Avg. Volume

76.227

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Recordati Industria Chimica E Farmaceutica S.p.A. Performance Analysis

Recordati Industria Chimica E Farmaceutica S.p.A. annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 1,853,307,00017.3%
20232023-12-31EUR 2,082,331,00012.4%
20242024-12-31EUR 2,341,559,00012.4%
20252025-12-31EUR 2,618,383,00011.8%
Recordati Industria Chimica E Farmaceutica S.p.A. annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 1.49-19.1%
20232023-12-31EUR 1.8624.6%
20242024-12-31EUR 1.997.0%
20252025-12-31EUR 2.126.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€697.36

+1.1%

Gross Profit

€497.97

+1.2%

Gross Margin

71.41%

+1.1%

Market Cap

€10.75BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€2.22

N/A

Employees

4,693

N/A

Net Income

€116.61

+1.3%

EBITDA

€256.61

+1.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€2.70K

-4.0%

Total Debt

€2.31K

+0.9%

Accounts Receivable

€651.84

+1.1%

Inventory

€550.34

+1.1%

Long Term Debt

€1.69K

+0.8%

Short Term Debt

€619.89

+1.6%

Return on Assets

9.43%

+1.1%

Return on Invested Capital

12.59%

+0.9%

Free Cash Flow

€207.46

+2.1%

Operating Cash Flow

€217.09

+2.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About RER1

What is the current price of Recordati Industria Chimica E Farmaceutica S.p.A.?

Recordati Industria Chimica E Farmaceutica S.p.A. is trading at €52.40 per share.

What is the 52-week range for Recordati Industria Chimica E Farmaceutica S.p.A.?

Over the past 52 weeks, Recordati Industria Chimica E Farmaceutica S.p.A. has traded between €43.92 and €54.40.

How much debt does Recordati Industria Chimica E Farmaceutica S.p.A. have?

As of the most recent reporting period, Recordati Industria Chimica E Farmaceutica S.p.A. reported total debt of €2.31B.

How much cash does Recordati Industria Chimica E Farmaceutica S.p.A. have on hand?

Recordati Industria Chimica E Farmaceutica S.p.A. reported €391.38M in cash and cash equivalents in its most recent financial results.

What is Recordati Industria Chimica E Farmaceutica S.p.A.’s dividend yield?

Recordati Industria Chimica E Farmaceutica S.p.A. currently has a dividend yield of 2.55%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services